Marco Bono
About
Marco Bono is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Marco Bono has authored 33 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Bono's work include Cancer Immunotherapy and Biomarkers (9 papers), BRCA gene mutations in cancer (8 papers) and PARP inhibition in cancer therapy (6 papers). Marco Bono is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), BRCA gene mutations in cancer (8 papers) and PARP inhibition in cancer therapy (6 papers). Marco Bono collaborates with scholars based in Italy, Argentina and France. Marco Bono's co-authors include Antonio Russo, Viviana Bazan, Giuseppe Badalamenti, Lorena Incorvaia, Nadia Barraco, Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Valerio Gristina and Alessia Fiorino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.
In The Last Decade
Marco Bono
31 papers receiving 440 citations
Peers
Marco Bono
Samuel Suzuki United States
Dilara Akhoundova Switzerland
Markus Mayrhofer Sweden
Nicole Kelbick United States
Gillianne Lai Singapore
Ninad Dewal United States
Jamileh Hashemi Sweden
Mark Dowar Canada
Sarah Abou Alaiwi United States
DC Betticher United Kingdom
Citations per year, relative to Marco Bono Marco Bono (= 1×)
peers
Samuel Suzuki
Countries citing papers authored by Marco Bono
Since
Specialization
Citations
This map shows the geographic impact of Marco Bono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bono more than expected).
Fields of papers citing papers by Marco Bono
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Marco Bono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bono. The network helps show where Marco Bono may publish in the future.
Co-authorship network of co-authors of Marco Bono
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Bono. A scholar is included among the top collaborators of Marco Bono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Bono. Marco Bono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Incorvaia, Lorena, Cláudia Marchetti, Chiara Brando, et al.. (2025). BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study. ESMO Open. 10(2). 104076–104076.
2.
Gristina, Valerio, Viviana Bazan, Nadia Barraco, et al.. (2025). On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study. Molecular Oncology. 19(5). 1422–1435.
3.
Incorvaia, Lorena, Tancredi Didier Bazan Russo, Valerio Gristina, et al.. (2024). The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors. npj Precision Oncology. 8(1). 190–190.
4.
Corsini, Lidia Rita, Chiara Brando, Alessandro Perez, et al.. (2024). 208P Role of plasma exosomes in crosstalk between immune system and hereditary ovarian cancer: Opportunity or challenge?. Annals of Oncology. 35. S300–S300.
5.
Gristina, Valerio, Alessandro Perez, Nadia Barraco, et al.. (2024). Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”. SHILAP Revista de lepidopterología. 3. 100136–100136.
6.
Russo, Tancredi Didier Bazan, Marco Bono, Valerio Gristina, et al.. (2024). Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors. Cancer Gene Therapy. 31(11). 1619–1631.
7.
Corsini, Lidia Rita, Daniele Fanale, Chiara Brando, et al.. (2024). 49P Prognostic relevance of baseline exosome-delivered PD-1, PD-L1, pan-BTN3As and BTN3A1 in advanced cholangiocarcinoma patients: Can immune checkpoints act as a sentinel for predicting survival?. Annals of Oncology. 35. S231–S231.
8.
Incorvaia, Lorena, Chiara Brando, Alessandro Perez, et al.. (2023). Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.. Journal of Clinical Oncology. 41(16_suppl). 10592–10592.
9.
Incorvaia, Lorena, Gaetana Rinaldi, Giuseppe Badalamenti, et al.. (2023). Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay. Therapeutic Advances in Medical Oncology. 15. 2596581–2596581.
10.
Fanale, Daniele, Lidia Rita Corsini, Chiara Brando, et al.. (2022). Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. Critical Reviews in Oncology/Hematology. 170. 103597–103597.
11.
Fanale, Daniele, Marco Bono, Alessia Fiorino, et al.. (2022). BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning. Critical Reviews in Oncology/Hematology. 172. 103626–103626.
12.
Fanale, Daniele, Alessia Fiorino, Lorena Incorvaia, et al.. (2021). Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome. Frontiers in Oncology. 11. 682445–682445.
13.
Bono, Marco, Daniele Fanale, Lorena Incorvaia, et al.. (2021). Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge. ESMO Open. 6(4). 100235–100235.
14.
Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2020). A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers. 12(11). 3396–3396.
15.
Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2020). Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes. Cancers. 12(5). 1158–1158.
16.
Fanale, Daniele, Lorena Incorvaia, Clarissa Filorizzo, et al.. (2020). Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers. 12(9). 2415–2415.
17.
Fanale, Daniele, Lorena Incorvaia, Marco Bono, et al.. (2020). 247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical background affects genetics. Annals of Oncology. 31. S338–S339.
18.
Accurso, Vincenzo, Marco Santoro, Salvatrice Mancuso, et al.. (2020). CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020008–e2020008.
19.
Mancuso, Salvatrice, Marco Santoro, Vincenzo Accurso, et al.. (2020). Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?. Oncology Research and Treatment. 43(10). 526–530.
20.
Garbo, Vincenzo Di, Domenico Di Raimondo, R. De Simone, et al.. (2000). Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response. European Journal of Clinical Pharmacology. 56(4). 277–284.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Samuel Suzuki Breakdown of academic impact, for papers by Dilara Akhoundova Breakdown of academic impact, for papers by Markus Mayrhofer Breakdown of academic impact, for papers by Nicole Kelbick Breakdown of academic impact, for papers by Gillianne Lai Breakdown of academic impact, for papers by Ninad Dewal Breakdown of academic impact, for papers by Jamileh Hashemi Breakdown of academic impact, for papers by Mark Dowar Breakdown of academic impact, for papers by Sarah Abou Alaiwi Breakdown of academic impact, for papers by DC Betticher